Prescription drug · ANDA
pemetrexed (pemetrexed disodium) NDC 70771-1691
Pemetrexed disodium 100 mg/4mL · Injection, Powder, Lyophilized, For solution · Intravenous · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1691-1 | 70771169101 | 1 VIAL in 1 CARTON (70771-1691-1) / 4 mL in 1 VIALMarketed from May 26, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- pemetrexed
- Generic name (nonproprietary)
- pemetrexed disodium
- Active ingredients
- Pemetrexed disodium — 100 mg/4mL
- Dosage form
- Injection, Powder, Lyophilized, For solution
- Route
- Intravenous
- Labeler
- Zydus Lifesciences Limited
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214073
- Marketing start
- Listing expires
- Other FDA classes
- Folic Acid Metabolism Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1691_fc5f4aa1-92c4-444b-8e64-53708c9a67bcSPL ID fc5f4aa1-92c4-444b-8e64-53708c9a67bcSPL set ID 6986de29-b077-48ac-ad2b-0cc478f72d89RxCUI 1728072, 1728077, 2601728UNII 2PKU919BA9
- Pharmacologic class
- Folate Analog Metabolic Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470771169101followed by a unit qualifier and the quantityPackage 70771-1691-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Other NDCs under ANDA 214073
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| pemetrexedpemetrexed disodium | Pemetrexed disodium 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Zydus Lifesciences Limited | 70771-1692 |
| pemetrexedpemetrexed disodium | Pemetrexed disodium 1000 mg/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | Zydus Lifesciences Limited | 70771-1693 |
| pemetrexedpemetrexed disodium | Pemetrexed disodium 100 mg/4mL | Injection, Powder, Lyophilized, For solutionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1654 |
| pemetrexedpemetrexed disodium | Pemetrexed disodium 500 mg/20mL | Injection, Powder, Lyophilized, For solutionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1655 |
| pemetrexedpemetrexed disodium | Pemetrexed disodium 1000 mg/40mL | Injection, Powder, Lyophilized, For solutionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1674 |